Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time

被引:0
作者
Mian Wang
Hui Lin Cheng
Violeta Lopez
Raghav Sundar
Janelle Yorke
Alex Molassiotis
机构
[1] The Hong Kong Polytechnic University,School of Nursing
[2] National University of Singapore,Alice Lee Centre for Nursing Studies
[3] The N.1 Institute of Health,Division of Nursing, Midwifery & Social Work
[4] National University of Singapore,Christie Patient Centred Research (CPCR)
[5] University of Manchester,undefined
[6] The Christie NHS Foundation Trust,undefined
来源
BMC Cancer | / 19卷
关键词
Cancer; Chemotherapy-induced peripheral neuropathy; Patient-reported outcome; Symptom clusters;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 221 条
[21]  
Kiernan MC(2010)Symptom clusters: myth or reality? Palliat Med 24 373-3422
[22]  
Kieffer JM(2012)Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy Clin Cancer Res 18 3180-218.e2
[23]  
Postma TJ(2015)Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance) J Clin Oncol 33 3416-1175
[24]  
van de Poll-Franse L(2017)Chemotherapy-induced neuropathy in cancer survivors J Pain Symptom Manag 54 204-87
[25]  
Mols F(2017)Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer Clin Neurophysiol 128 1166-141
[26]  
Heimans JJ(2006)Electrophysiological evaluation of visual pathways in paclitaxel-treated patients J Neuro-Oncol 77 79-153
[27]  
Cavaletti G(2018)Living with chemotherapy-induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors Eur J Oncol Nurs 36 135-11
[28]  
Aaronson NK(2017)Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer Gynecol Oncol 145 148-3356
[29]  
Wolf SL(2018)Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy Eur J Oncol Nurs 32 1-24
[30]  
Barton DL(2010)Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer Cancer. 116 3348-53